CLINICAL_TRIALS
trial_result
· 2025-09-11
Clinical Trial Update: Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy [Phase 2]
Summary
A Phase 2 study of Tideglusib in adolescent and adult patients with myotonic dystrophy type 1 has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AMO Pharma Limited | Conditions: Myotonic Dystrophy 1 | Phase 2 | Status: COMPLETED | Results posted: 2025-09-11